Innovating Biopharmaceuticals: The Potential of Harbour HCAb PLUS™ in Therapeutic Development
In the rapidly evolving world of biopharmaceuticals, Harbour HCAb PLUS™ represents a significant leap forward in therapeutic modalities. Developed by Nona Biosciences, this technology leverages the unique properties of heavy chain-only antibodies (HCAb) to offer versatile solutions across a broad spectrum of diseases, showcasing the power of modern science in addressing complex health challenges. Harbour …






